Home Newsfeeds Raymond James Downgrades Maxeon Solar Technologies to Market Perform

Raymond James Downgrades Maxeon Solar Technologies to Market Perform

Raymond James analyst Pavel Molchanov downgrades Maxeon Solar Technologies (NASDAQ:MAXN) from Outperform to Market Perform.

byBenzinga Newsdesk

August 16, 2022

1 minute read

Raymond James analyst Pavel Molchanov downgrades Maxeon Solar Technologies (NASDAQ:MAXN) from Outperform to Market Perform.

Eiger BioPharma’s Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths

By Vandana Singh

February 9, 1:32 PM

Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) announced the publication of data from the investigator-sponsored Phase 3 TOGETHER study in patients with COVID-19 in…

EIGR

News

‘This Major Intel Security Flaw Could Leave Millions Of Users At Risk’ – Tech Radar

By Happy Mohamed

August 9, 12:27 PM

https://www.techradar.com/pro/security/this-major-intel-security-flaw-could-leave-millions-of-users-at-risk A major vulnerability, dubbed Downfall, has been found lurking in most Intel chips designed over the

INTC

This Stock Earns Price Bump, Bullish Pitch On Recent Positive Migraine Drug Data

By Vandana Singh

September 21, 2:33 PM

Satsuma Pharmaceuticals Inc (NASDAQ:STSA) announced positive results from the ASCEND open-label, long-term safety trial for STS101 intranasal dry powder dihydroergotamine (DHE)…

STSA

Arista Networks, Zoetis And This Airline Stock On CNBC’s ‘Final Trades’

By Lisa Levin

February 27, 9:47 AM

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc (NYSE: ZTS) as her

ALK

Raymond James Downgrades Maxeon Solar Technologies to Market Perform

Related Posts

Eiger BioPharma’s Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths

‘This Major Intel Security Flaw Could Leave Millions Of Users At Risk’ – Tech Radar

This Stock Earns Price Bump, Bullish Pitch On Recent Positive Migraine Drug Data

Arista Networks, Zoetis And This Airline Stock On CNBC’s ‘Final Trades’